Osteonecrosis of the jaw among patients receiving antiresorptive medication: A 4-year retrospective study at a tertiary cancer center, Kerala, India
Purpose: Osteonecrosis of the jaw (ONJ) is a rare but complicated side effect of antiresorptive medications. The aim of the study is to evaluate the dental and drug-related factors related to ONJ among patients on these drugs at a tertiary cancer center, India. Methodology: A retrospective record re...
Main Authors: | Pramod S Sankar, S A Thilak, P Nayak, J P Tripathy, B Satheesan, A V Rajitha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Contemporary Clinical Dentistry |
Subjects: | |
Online Access: | http://www.contempclindent.org/article.asp?issn=0976-237X;year=2018;volume=9;issue=1;spage=35;epage=40;aulast=Sankar |
Similar Items
-
Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01) -
Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01) -
Medication-related osteonecrosis of the jaw in a patient with multiple myeloma
by: Nupur Bhardwaj, et al.
Published: (2015-01-01) -
Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
by: Gioacchino Catania, et al.
Published: (2016-12-01) -
Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)